Serina Therapeutics Inc
(SER)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,986 | -5,464 | -3,031 | -12,154 | -9,443 |
| Depreciation Amortization | 1,061 | 651 | 307 | 1,005 | 674 |
| Accounts receivable | 52 | 82 | 11 | -232 | -103 |
| Other Working Capital | -193 | -83 | 232 | -410 | 2 |
| Other Operating Activity | 869 | 506 | 417 | 1,631 | 1,121 |
| Operating Cash Flow | $-6,197 | $-4,308 | $-2,064 | $-10,160 | $-7,749 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | -8 | -4 | -641 | -346 |
| Sale Of Investment | N/A | N/A | N/A | 354 | 354 |
| Other Investing Activity | 0 | 0 | 0 | -74 | -74 |
| Investing Cash Flow | $-20 | $-8 | $-4 | $-361 | $-66 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -15 | -15 | -15 | -35 | -22 |
| Other Financing Activity | 4,984 | 3,007 | 200 | 6,300 | 5,000 |
| Financing Cash Flow | $4,969 | $2,992 | $185 | $6,265 | $4,978 |
| Exchange Rate Effect | 3 | 5 | -1 | 1 | -2 |
| Beginning Cash Position | 2,452 | 2,452 | 2,452 | 6,707 | 6,707 |
| End Cash Position | 1,207 | 1,133 | 568 | 2,452 | 3,868 |
| Net Cash Flow | $-1,245 | $-1,319 | $-1,884 | $-4,255 | $-2,839 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,197 | -4,308 | -2,064 | -10,160 | -7,749 |
| Capital Expenditure | -20 | -8 | -4 | -641 | -346 |
| Free Cash Flow | -6,217 | -4,316 | -2,068 | -10,801 | -8,095 |